Abstract
BackgroundAmong the unmet needs in psoriatic arthritis (PsA), the discovery of molecular players and biomarkers of disease activity or clinical remission achievement, remains unsolved. Metabolomics is a valuable technology in...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
